Novartis AG 2021 SR
The report details Novartis' sustainability and social impact efforts in the United States for the 2021 fiscal year. Key highlights include the launch of the Beacon of Hope initiative, a ten-year collaboration aimed at addressing systemic racism and health disparities. The company achieved 49% female representation in US management and invested USD 3.17 billion in domestic research and development. Furthermore, Novartis committed to a net-zero carbon target by 2040 and reported providing over USD 4 billion in free medicines through its Patient Assistance Foundation. The report also features the company's first US-specific materiality assessment to guide its ESG strategy.
Company: Novartis AG
Sector: Manufacturing
Country: Switzerland
Year: 2021
Type: SR
Pages: 28
Back to company
Novartis AG
Novartis In Society Report (Us)
The report details Novartis' sustainability and social impact efforts in the United States for the 2021 fiscal year. Key highlights include the launch of the Beacon of Hope initiative, a ten-year collaboration aimed at addressing systemic racism and health disparities. The company achieved 49% female representation in US management and invested USD 3.17 billion in domestic research and development. Furthermore, Novartis committed to a net-zero carbon target by 2040 and reported providing over USD 4 billion in free medicines through its Patient Assistance Foundation. The report also features the company's first US-specific materiality assessment to guide its ESG strategy.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jan 1, 2021 - Dec 31, 2021
Fiscal Year
2021
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Standard
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women in Management
Net Zero Target
Employees